Constitutive expression and localization of the major drug metabolizing enzyme, cytochrome P4502D in human brain

被引:57
作者
Chinta, SJ
Pai, HV
Upadhya, SC
Boyd, MR
Ravindranath, V
机构
[1] Natl Brain Res Ctr, New Delhi 110067, India
[2] Natl Inst Mental Hlth & Neurosci, Dept Neurochem, Bangalore 560029, Karnataka, India
[3] NCI, Mol Targets Drug Discovery Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA
来源
MOLECULAR BRAIN RESEARCH | 2002年 / 103卷 / 1-2期
关键词
human brain; drug metabolism; cytochrome p450; psychoactive drug; monooxygenase; cytochrome P4502D;
D O I
10.1016/S0169-328X(02)00177-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cytochrome P4502D6, an important isoform of cytochrome P450, mediates the metabolism of several psychoactive drugs in liver. Quantitatively, liver is the major drug metabolizing organ, however metabolism of drugs in brain could modulate pharmacological and pharmacodynamic effects of psychoactive drugs at their site of action and explain some of the variation typically seen in patient population. We have measured cytochrome P450 content and examined constitutive expression of CYP2D mRNA and protein in human brain regions by reverse transcription polymerase chain reaction, Northern and immunoblotting and localized it by in situ hybridization and immunohistochemistry. CYP2D mRNA was expressed constitutively in neurons of cerebral cortex, Purkinje and granule cell layers of cerebellum, reticular neurons of midbrain and pyramidal neurons of CA1, CA2 and CA3 subfields of hippocampus. Immunoblot studies demonstrated the presence of cytochrome P4502D protein in cortex, cerebellum, midbrain, striatum and thalamus of human brain. Immunohistochemical localization showed the predominant presence of cytochrome P4502D not only in neuronal soma but also in dendrites of Purkinje and cortical neurons. These studies demonstrate constitutive expression of cytochrome P4502D in neuronal cell population in human brain, indicating its possible role in metabolism of psychoactive drugs directly at or near their site of action, in neurons, in human brain. (C) 2002 Elsevier Science BY. All rights reserved.
引用
收藏
页码:49 / 61
页数:13
相关论文
共 36 条
[1]  
BHAMRE S, 1992, BIOCHEM PHARMACOL, V44, P223
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
Brosen K, 1993, Psychopharmacol Ser, V10, P199
[4]   RECENT DEVELOPMENTS IN HEPATIC DRUG OXIDATION - IMPLICATIONS FOR CLINICAL PHARMACOKINETICS [J].
BROSEN, K .
CLINICAL PHARMACOKINETICS, 1990, 18 (03) :220-239
[5]   A gene for Parkinson disease [J].
Chase, TN .
ARCHIVES OF NEUROLOGY, 1997, 54 (09) :1156-1157
[6]  
CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532
[7]  
DEMONTELLANO O, 1986, CYTOCHROME P 450 STR
[8]  
GONZALEZ F J, 1988, Genomics, V2, P174, DOI 10.1016/0888-7543(88)90100-0
[9]   HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS [J].
GONZALEZ, FJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) :346-352
[10]  
GRAM TE, 1986, ANNU REV PHARMACOL, V26, P259